1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. MONOGRAM ORTHOPAEDICS INC
Monogram Orthopaedics Inc XNAS: MGRM

Watchlist

Portfolio

Alert


Insider Trading disclosures for Monogram Orthopaedics Inc

The latest disclosure was made by Paul H. Riss in Monogram Orthopaedics Inc where a trade of 40,000 Stock Option done was reported to US exchanges on Oct. 7, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Paul H. Riss Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 40,000 0 - - Stock Option
Benjamin Sexson Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 1,560,000 0 - - Stock Option
Benjamin Sexson Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 4,006,330 0 - - Common Stock
Noel Knape See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 115,000 0 - - Stock Option
Noel Knape See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 296,385 0 - - Common Stock
Douglas Unis Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 3,532,622 0 - - Common Stock
Douglas Unis Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 1,475,000 0 - - Stock Option
Kamran Shamaei See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 2,926 0 - - Common Stock
Kamran Shamaei See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Oct 2025 1,310,000 0 - - Stock Option
Paul H. Riss Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2025 10,000 40,000 - - Stock Option
Benjamin Sexson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2025 160,000 1,560,000 - - Stock Option
Noel Knape Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2025 40,000 40,000 - - Stock Option
Douglas Unis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2025 35,000 1,475,000 - - Stock Option
Kamran Shamaei Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2025 250,000 250,000 - - Stock Option
Noel Knape Chief Financial Officer Grant, award, or other acquisition of securities at price $ 2.08 per share. 25 Nov 2024 288,461 288,461 - 2.1 599,999 Common Stock
Noel Knape Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2024 25,000 75,000 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters